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Abstract In utero exposure to tobacco smoke has been
related to numerous adverse health effects in new-borns,
infants, children, adolescents and adults. The aim of this
review was to summarise findings on prenatal nicotine
exposure and its relationship with behavioural problems in
the offspring. The majority of studies, and especially sev-
eral recent epidemiological studies, observed a higher
likelihood for attention-deficit/hyperactivity disorder
(ADHD) or ADHD symptoms in exposed subjects. How-
ever, both human and animal studies have failed to provide
clear evidence on causality. Existing literature on studies
investigating the association between prenatal nicotine
exposure and conduct or externalising problems in the
offspring suggests a causal effect. The establishment of a
final conclusion concerning the relationship between pre-
natal nicotine exposure and internalising problems in the
offspring is complicated by insufficient data and mixed
results in epidemiological studies. Prenatal nicotine expo-
sure has been associated with altered brain structure and
function in human offspring, and a proposed biological
mechanism is related to nicotine’s adverse influence on
neurotransmitter systems during brain development. In
conclusion, establishing a statement on the causality of the
relationship between prenatal nicotine exposure and
behavioural problems in children remains a challenging
task. Nevertheless, considering the results of an increasing
number of studies which link prenatal exposure to nicotine
to externalising problems applying different methodologies
to account for confounding and in view of other adverse
health effects known to be caused by this exposure, parents
should consider smoking cessation.
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Maternal smoking during pregnancy has been related to
multiple adverse effects including pregnancy complica-
tions and risks of preterm delivery, lower birth weight,
reduced lung function in infants and sudden infant death
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syndrome [1]. Another field of research links in utero
exposure to tobacco smoke to behavioural problems such
as attention-deficit/hyperactivity disorder (ADHD), con-
duct problems, depression and anxiety in the offspring.
The Global Burden of Disease study from 2010 esti-
mated that mental and behavioural disorders cause around
185 million disability-adjusted life years (DALYs) [2].
Estimates for behavioural disorders in childhood were
5.8 million DALYs for conduct problems and half a mil-
lion for ADHD [2]. However, even though a large number
of studies support a relationship between intrauterine
exposure to tobacco smoke and later behavioural problems
and plausible biological mechanisms exist, some studies
reported no association or only a weak one. Furthermore,
many lifestyle, socioeconomic, cultural and genetic factors,
in which smokers differ from non-smokers in non-random
ways, complicate this relationship and make it difficult to
come to a final conclusion on causality. Nicotine is just one
component of tobacco smoke and smokeless tobacco pro-
ducts. However, there is increasing evidence for specific
effects of prenatal nicotine exposure that leads to adverse
health effects in new-borns, infants, children, adolescents
and adults.
The objective of this review was to provide an overview
on prenatal nicotine exposure and its relationship with off-
spring behaviour. As a broad range of symptoms and disor-
ders is summarised under this term, we will summarise
findings from previous reviews and complement them with
relevant information from recent publications in the
respective fields of research. First, main pathways of nicotine
exposure during pregnancy are outlined. Then, the epide-
miology of maternal smoking during pregnancy is covered
including factors affecting the likelihood of smoking ces-
sation. Subsequently, nicotine metabolism, methods of
assessing prenatal exposure to nicotine and physical findings
associated with this exposure are briefly described. The main
section covers the specific topic of offspring behavioural
problems following prenatal nicotine exposure. This section
is subdivided into an overview of the literature covering (1)
hyperactivity or inattention problems such as ADHD, (2)
externalising problems such as conduct disorder and anti-
social behaviour and (3) emotional or internalising problems
such as depression and anxiety. Lastly, results from brain
imaging studies and possible mechanisms of adverse effects
of nicotine to the developing brain are discussed, followed by
a final conclusion.
Definition of prenatal exposure to nicotine and its
assessment
Active maternal smoking is just one pathway of foetal
exposure to nicotine. Others include an exposure of the
pregnant woman to environmental tobacco smoke (ETS)
due to smoking behaviours of other people, maternal use of
smokeless tobacco products such as chewing tobacco and
maternal use of non-tobacco products containing nicotine
such as medication during a nicotine replacement therapy
(NRT). ETS consists of mainstream smoke exhaled by the
smoker and sidestream smoke which is released by the
smouldering cigarette [3]. Tobacco smoke itself is a com-
plex mixture of gases and particulate matter components
[3]. One of these constituents is nicotine. Furthermore,
prenatal exposure to nicotine is often difficult to quantify as
nicotine concentration in different tobacco products varies
and is also dependent on individual smoking characteristics
such as puffing intensity [4].
To date, human studies, which analysed the association
between prenatal nicotine exposure and behavioural prob-
lems, have defined this exposure either by active maternal
smoking or by ETS exposure of the mother during
pregnancy.
Nicotine metabolism and its transfer from mother
to the foetus
Nicotine is a chemical compound, an alkaloid, found in
tobacco smoke, smokeless tobacco products and nicotine
replacement products [5]. It can be absorbed through the
mouth by chewing, the lungs as smoke or the skin via an
NRT patch [5]. Once nicotine has entered the bloodstream,
it is distributed throughout the body to various tissues such
as the brain, lung and liver [5]. In the liver, it is metabo-
lised and finally excreted in urine [5]. Nicotine’s major
metabolite is cotinine whose main metabolic product in
turn is trans-30-hydroxycotinine [5]. By crossing the pla-
cental barrier, nicotine can be transferred from the maternal
circulation to the foetus [6]. Cotinine measurements taken
in the first trimester indicate an accumulation in foetal
fluids: cotinine concentrations in amniotic fluid and foetal
serum were higher than in maternal serum regardless of
whether the mother is an active or passive smoker [7]. The
main pathway of elimination of nicotine from the foetal
circulation occurs by re-diffusion across the placenta into
the maternal circulation [8].
Assessment of prenatal exposure to nicotine
Prenatal exposure to nicotine can be assessed via ques-
tionnaires asking, for example, about maternal smoking or
ETS exposure during pregnancy. This method is often
chosen for epidemiological studies as past, long-term and
current exposures can be inexpensively assessed in large
samples [3, 9]. However, this method has several draw-
backs. First, this method is prone to exposure misclassifi-
cation such as recall bias, under-reporting or concealment
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of smoking, which might be due to awareness of numerous
negative health effects for children exposed to tobacco
smoke in utero [3, 9]. Second, a single question on whether
the mother smoked during pregnancy does not adequately
address the amount of exposure and smoking patterns: a
‘‘yes’’ answer might include total abstinence after becom-
ing aware of the pregnancy. Therefore, a detailed set of
questions on numbers of cigarettes smoked per day during
pregnancy or during certain trimesters and on smoking
cessation should preferably be used.
A more objective method of ascertaining prenatal
exposure is the measurement of exposure-specific bio-
markers in biological matrices of mother and/or child.
Candidate biomarkers with high specificity for active or
passive tobacco smoking or usage of medication containing
nicotine are nicotine itself and its metabolites, such as
cotinine or trans-30-hydroxycotinine [10, 11]. While nico-
tine has a short half-life of 2 h, the half-life of cotinine is
on average 16 h [10]. Thus, measurements of nicotine or
cotinine in blood, urine and saliva reflect recent exposures
within the last few hours or last few days, respectively, and
are susceptible to variations in exposure. This limits the
usage for the assessment of long-term exposures. In new-
borns, however, a longer half-life of nicotine and similar
half-life of cotinine compared to adults have been reported
which have been suggested to be due to differences in the
sensitivity of the clearance rates of these two chemicals to
alterations of hepatic blood flow [5]. Maternal matrices
such as blood, urine, saliva and hair can be used for
detection of the above-mentioned biomarkers to assess
ETS exposure or active smoking [10, 12]. Llaquet et al.
[13] provide an overview on possible biological matrices in
the child for detection of prenatal ETS exposure. Mea-
surements of nicotine or its metabolites in cord serum and
neonatal urine reflect the exposure to ETS shortly before
delivery [13]. Other matrices such as hair, nails, amniotic
fluid and meconium, in which nicotine or its metabolites
accumulate or are incorporated during formation, have
longer detection periods ranging from first to last trimester
[13]. It is often not feasible to differentiate clearly between
children of mothers exposed to ETS during pregnancy and
those who were not. Two studies [14, 15] reported no
detectable levels of nicotine or its metabolites in amniotic
fluid or meconium of new-borns whose mother was
exposed to ETS during pregnancy. In another study, the
measurement of trans-30-hydroxycotinine (adjusted for
creatinine) in urine of new-borns showed slight but sig-
nificant differences between children of mothers exposed
to ETS and those unexposed [16]. For detection of foetal
tobacco smoke exposure in late pregnancy, the measure-
ment of cotinine in cord serum seems to be the most
promising biomarker due to its ability to distinguish
between active maternal smoking, maternal ETS exposure
and no exposure [13].
Lastly, indoor nicotine concentrations can be measured
in the homes of pregnant women using active or passive air
samplers [17, 18]. This approach is mainly relevant for the
assessment of ETS exposure.
Epidemiology
Epidemiological studies using data from European birth
cohorts reported maternal smoking prevalences between 14
and 38 % [19–24]. The European Perinatal Health Report
from 2010 estimates the prevalence of maternal smoking
during pregnancy or in the last trimester to be above 10 %
in many countries, varying between under 5 % in Sweden
and Lithuania to 19 % in Scotland [25]. Compared to the
report from 2004, a slight decrease of about 1–3 % of
mothers who smoked in the third trimester was observed
[25]. Cnattingius [26] reviewed the epidemiology of
smoking during pregnancy and also concluded that the
prevalence had declined. While one-fourth and one-fifth of
pregnant women in Sweden and the USA, respectively,
reported smoking around 1990, these values declined to
about one-eighth in 2000. Denmark showed slightly higher
but similarly declining rates of approximately one-third at
the beginning and one-fourth at the end of the nineties [26].
In 2004–2005, Bloch et al. [27] conducted a study on
tobacco use and ETS exposure of pregnant women in nine
developing countries. Percentages of women who reported
active smoking ranged from 3 % (Pakistan) to 18 %
(Uruguay). Estimates for ETS exposure at home ranged
between 17 % (Democratic Republic of Congo) and 92 %
(Pakistan) [27].
A wide range of smoking cessation rates during preg-
nancy was reported with 27–47 % in Europe, 23–43 % in
the USA, 62–70 % in Japan and 4–47 % in other countries
[28].
However, in spite of declining prevalences of smoking
during pregnancy in most developed countries, and
potentially increasing prevalences in some developing
countries, exposure to nicotine during pregnancy is still a
problem worldwide.
Another important aspect of the epidemiology of
smoking during pregnancy is the constellation of factors
associated with likelihood of quitting. Chances of quitting
are lower in mothers with lower social status, smoking
partner, higher degree of addiction, higher parity [28] and
psychological correlates such as a history of conduct
problems in childhood [29].
Finally, since most epidemiological studies used ques-
tionnaire-based exposure assessment scenarios, it has to be
Eur Child Adolesc Psychiatry (2014) 23:913–929 915
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kept in mind that the reported findings cannot be inter-
preted as effects of pure nicotine exposure but rather as
those of tobacco smoke, which, apart from nicotine, con-
tains numerous other toxicants.
Physical findings
Active maternal smoking is associated with a wide range of
adverse health effects on the new-born. It is known to
decrease birth weight, following a dose–response rela-
tionship [30, 31]. Other effects include increased risks for
pregnancy complications and preterm delivery (\37 weeks
of completed gestation), low birth weight (\2,500 g) and
sudden infant death syndrome [1]. Maternal exposure to
ETS during pregnancy is related to a similar range of
outcomes. Salmasi et al. [32] conducted a meta-analysis on
perinatal findings related to ETS exposure in pregnant
women. Significant associations were found between ETS
exposure and a lower birth weight, congenital anomalies
and a longer birth length. ETS-exposed children further
showed trends for smaller neonate head circumferences
and risk for low birth weight [32]. Leonardi-Bee et al. [33]
reported an increased risk for stillbirth of non-smoking
women exposed to ETS while pregnant.
Nicotine exposure during pregnancy has been related to
adverse effects on the lung and the respiratory system,
including increased risks for asthma, wheeze and airway
hyper-responsiveness in children [34–36]. Out of other
components contained in tobacco smoke, nicotine has been
suggested to be the main candidate concerning negative
effects on pulmonary development [34]. Prenatal exposure
to nicotine is related to structural as well as functional
alterations in lung development, which are potentially
related to an increased risk for obstructive lung disease and
accelerated lung ageing in later years [34]. Finally, as
prenatal nicotine exposure is a risk factor for low birth
weight and as low birth weight is associated to adverse
effects on lung development, nicotine might be indirectly
related to adverse pulmonary development via low birth
weight [37].
Bakker et al. [38] reviewed cardiovascular and meta-
bolic influences of foetal smoke exposure. They reported
that maternal smoking during pregnancy is associated with
higher blood pressure in children. Furthermore, prenatal
exposure to maternal smoking may directly or indirectly
(via low birth weight) be related to obesity, adverse car-
diovascular diseases and type 2 diabetes in later life [38].
While the association between maternal smoking during
pregnancy and overweight or obesity in the children is
suggested to be causal, no definitive conclusions for the
outcomes of type 2 diabetes and the metabolic syndrome
can be drawn from the small number of studies [39].
Moreover, there seems to be no association between smoke
exposure during pregnancy and type 1 diabetes [39]. In
short, findings for cardiovascular and metabolic effects of
foetal smoke exposure are mixed and establishing state-
ments about causality therefore stays difficult.
Neuropsychological, behavioural and psychiatric
findings
Prenatal nicotine exposure is also associated with increases
in behavioural and cognitive problems.
Briefly, no definitive conclusion can be drawn regarding
the association between prenatal exposure to nicotine or
tobacco smoke and impairment of cognitive function in the
children [31, 40, 41]. Differing results may be explained by
incomplete control for confounding variables such as
maternal age, education, intelligence quotient and socio-
economic status [31]. Clifford et al. [41] reviewed obser-
vational studies between 2000 and 2011 on the association
between active maternal smoking during pregnancy and
cognitive outcomes in children; they concluded that the
most consistent results were observed for reduced aca-
demic achievement and impaired intellectual abilities.
Animal studies on the effects of developmental nicotine on
cognitive function in offspring show a similarly inconclu-
sive picture with conflicting results [31].
Two very recent studies in children from the Avon
Longitudinal Study of Parents and Children (ALSPAC), a
prospective UK birth cohort, related prenatal nicotine
exposure to impaired reading performance [42] and
increased risk of language impairment and poor perfor-
mance on language tasks [43].
The main objective of this review was to provide an
overview on the topic of prenatal nicotine exposure and
child behavioural problems subdivided into attention,
externalising and internalising problems. Literature search
was performed between November 2013 and January 2014.
Initially, the PubMed database was searched by using the
following terms: (‘‘nicotine’’ OR ‘‘tobacco’’ OR ‘‘ciga-
rette’’ OR ‘‘smoking’’) AND (‘‘prenatal’’ OR ‘‘pregnancy’’
OR ‘‘gestational’’ OR ‘‘trimester’’ OR ‘‘in utero’’) AND
(‘‘neonate’’ OR ‘‘infant’’ OR ‘‘child’’ OR ‘‘children’’ OR
‘‘adolescent’’) in combination with keywords for (1)
ADHD and symptoms of hyperactivity or inattention
(‘‘attention-deficit/hyperactivity disorder’’ OR ‘‘ADHD’’
OR ‘‘hyperactivity’’ OR ‘‘inattention’’), (2) conduct or
externalising behaviours and antisocial behaviour (‘‘con-
duct problems’’ OR ‘‘conduct disorder’’ OR ‘‘oppositional
defiant disorder’’ OR ‘‘externalizing’’ OR ‘‘externalising’’
OR ‘‘aggression’’ OR ‘‘antisocial’’) and (3) depression,
anxiety and internalising disorders (‘‘depression’’ OR
‘‘anxiety’’ OR ‘‘internalizing’’ OR ‘‘internalising’’ OR
916 Eur Child Adolesc Psychiatry (2014) 23:913–929
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‘‘emotional problems’’ OR ‘‘emotional disorders’’). Further
articles were identified via reference lists from earlier
review articles.
Due to the large number of publications published to
date in this field, this review will provide a comprehensive
but not exhaustive overview on the current knowledge by
summarising the results of previous review articles com-
bined with findings from key publications and relevant
recent publications in the respective fields of research.
Details of the original publications mentioned in the text
can be found in Table 1.
ADHD and symptoms of hyperactivity or inattention
An association between gestational exposure to nicotine or
tobacco smoke and ADHD in children has been reported
from many studies; results were summarised in several
reviews (e.g. [31, 40, 44–46]). Linnet et al. [45] reviewed
24 studies published between 1975 and 2002 investigating
the relationship between prenatal maternal smoking and
ADHD or ADHD symptoms in the children. The authors
concluded that most studies reported an increased risk for
the development of such problems in children of smoking
mothers, some even showing a dose–response effect in the
association. However, as there were several serious short-
comings such as methodological issues related to retro-
spectively collected data, rough estimation of exposure by
a dichotomous smoke exposure variable and statistical
issues related to power, no final statement on causality was
possible [45].
Latimer et al. [44] reviewed prenatal or early post-natal
environmental risk factors associated with disruptive
behaviour disorders. Eleven studies investigated the role of
maternal smoking during pregnancy: eight of them,
including population-based and case–control studies of
good quality, supported the presence of a link to an
increased risk for ADHD in the offspring.
Furthermore, results from about 1,600 children of the
German birth cohort study LISAplus also support an
association between maternal smoking during pregnancy
and hyperactivity or inattention problems in 10-year-olds
[22].
In a population-based record linkage case–control study
of young non-Aboriginal Australians (about 1,700 cases
and 3,850 controls), Silva et al. [47] recently observed that
maternal smoking is a risk factor for clinically defined
ADHD with additional prescription of stimulant medica-
tion. The association remained significant for both sexes
even after adjustment for several characteristics related to
pregnancy and birth (boys: odds ratio (OR) = 1.86, 95 %
confidence interval (CI): 1.53–2.27; girls: OR = 1.67,
95 %CI: 1.07–2.61).
Thus, both the consistency of results across many
studies and different study designs and the presence of
dose–response relationships between exposure and out-
come in some studies support the hypothesis of a causal
association. A further aspect is related to the ETS exposure
of women who are non-smokers during pregnancy. This
exposure can be due to ETS exposure at home by the
partner or other household members or it can be an expo-
sure at the workplace. Several studies have compared the
effects of active maternal smoking during pregnancy with
those resulting from ETS exposure (e.g. [20, 48–50]).
Gatzke-Kopp et al. [48] observed a higher risk for
ADHD symptoms not only in children exposed to maternal
smoking during pregnancy but also in those whose mother
did not smoke but was exposed to ETS during gestation.
A very recent study by Keyes et al. [49] compared the
influence of maternal and/or paternal smoking on offspring
hyperactivity at the age of 10 years. In unadjusted analy-
ses, maternal as well as paternal smoking during pregnancy
was related to increased offspring hyperactivity, respec-
tively. After adjustment for partner’s smoking behaviour
and accounting for several covariates, the association
between maternal smoking and hyperactivity in the chil-
dren remained stable, but the association with paternal
smoking was attenuated to non-significance. Furthermore,
no increased risk for hyperactivity could be observed in
children whose father smoked during pregnancy and whose
mother did not smoke. Nomura et al. [50] conducted a
similar study in about 200 preschool children (3–4 years
old). They observed an increased risk of ADHD symptoms
only for children exposed to maternal smoking but not for
those exposed to paternal smoking, even after adjustment
for a series of confounders including ADHD symptoms of
the parents, thereby decreasing the chance for confounding
by genetic factors.
Langley et al. [20] used data from over 8,000 children of
the ALSPAC prospective birth cohort study. They com-
pared the risks of ADHD symptoms in children aged
7.5 years whose mother smoked during pregnancy, with
those whose mother did not smoke but was exposed to the
smoking behaviour of the father. Furthermore, they asses-
sed the effect of passive smoking in families in which
neither parent smoked but where the mother reported ETS
exposure at work or living with household members who
smoked. Maternal smoking and paternal smoking (even in
the absence of maternal smoking) were both observed to be
associated with increased ADHD symptoms in the off-
spring, while passive smoking was not. The authors con-
cluded that the associations between maternal smoking and
ADHD in the children may be confounded by genetic
factors or factors on the household level and are to a lesser
extent attributable to causal effects of an exposure in utero
[20].
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Further studies that were able to control for genetic
factors suggest that the association between maternal
smoking during pregnancy and ADHD might not be causal
(e.g. [51, 52]).
Thapar et al. [51] tested the association with maternal
smoking in children conceived with assisted reproductive
technologies, comparing the ADHD risk of children
genetically related and unrelated to the gestational carrier.
In genetically related mother–child pairs, maternal smok-
ing during pregnancy was related to an increased risk for
ADHD symptoms in the offspring, while no association
was observed for genetically unrelated pairs. This obser-
vation suggests that the effect might be rather attributed to
inherited characteristics than to the exposure to prenatal
smoking [51].
D’Onofrio et al. [52] compared the ADHD traits of
siblings with and without prenatal maternal smoke expo-
sure in order to account for familial and genetic effects.
When children whose mother smoked during pregnancy
were compared to unrelated children without prenatal
smoke exposure, they showed a significantly increased risk
for ADHD symptoms. However, in siblings who differed in
their exposure to maternal smoking during pregnancy, the
association between smoking and subsequent ADHD
symptoms was small and not significant.
Abbott et al. [31] provided an overview on findings
from animal studies exploring whether prenatal exposure
to tobacco smoke is associated with ADHD-like symp-
toms. Most studies used nicotine instead of tobacco smoke
and hyperactivity measured by increased locomotor
activity was usually chosen as indicator for ADHD
symptoms. Studies in mice mostly reported increased
locomotor activity after prenatal nicotine exposure, but
studies in rats were less consistent [31]. Furthermore, the
authors stated that increased activity might not be repre-
sentative of ADHD-like behaviour in rodents, as other
symptoms such as inattention are not considered [31].
Moreover, several methodological issues complicate the
transfer of results from rodent studies to humans. Dwyer
et al. [53] mention three caveats: first, human foetuses are
born at a more mature stage of brain development than
are rodents. The first two trimesters of human develop-
ment correspond approximately to the full gestational
development of rodents, and the early post-natal period of
rodents is used as model for the third trimester develop-
ment of human foetuses. Second, the effects of a contin-
uous exposure to nicotine as effected in rodent models
might be different from an intermittent exposure related to
variations in nicotine levels such as it is the case for
human smoking. Third, animal models with a nicotine
exposure do not reflect the exposure to tobacco smoke in
humans as tobacco smoke contains numerous other
chemicals besides nicotine [53].
In summary, the majority of studies, and especially
several recent epidemiological studies, observed a higher
likelihood for ADHD or ADHD symptoms in subjects
prenatally exposed to nicotine. However, both human and
animal studies have failed to provide clear evidence on
causality.
Conduct or externalising behaviours and antisocial
behaviour
Several review articles (e.g. [54, 55]) summarised the
association between prenatal exposure to nicotine and
conduct or externalising problems. The authors concluded
that the existing literature strongly indicates an increased
risk, but no causal association could be established due to
methodological limitations.
Further support for an increased risk comes from the
study of Gatzke-Kopp et al. [48] who observed that not
only active maternal smoking, but also non-smoking
mother’s ETS exposure, during pregnancy is related to
higher symptom scores for conduct disorder in the
offspring.
Two other studies investigated the association between
maternal smoking during pregnancy and increased risk for
externalising problems in relatively young children at an
age of 18 months [56] and 4 years [19]. Using data from
the population-based Norwegian Mother and Child Cohort
Study with a large study sample (N [ 22,500), Stene-
Larsen et al. [56] reported a significantly increased risk
for externalising problems for 18-month-old children
whose mother smoked more than 10 cigarettes per day
(OR = 1.32, 95 % CI: 1.03–1.70) but not for those who
smoked less. The authors additionally reported no sex
difference in the association [56]. Brion et al. [19] ana-
lysed the association of maternal smoking during preg-
nancy with conduct or externalising problems in 4-year-
olds from two birth cohorts, one from a middle-income
country (Brazilian Pelotas study) and one from a high-
income country (British ALSPAC study). A significant
effect was (1) present in both studies, (2) persisted even
after adjustment for confounders such as socioeconomic
status and parental psychopathology and (3) was also
robust to adjustment for paternal smoking during
pregnancy.
Recently, O’Brien et al. [57] reported a gene x envi-
ronment interaction for a dopamine transporter gene
(DAT1) variant that modifies the risk for externalising
problems in male but not in female adolescents after pre-
natal exposure to maternal smoking which was assessed via
repeated cotinine-corrected reports.
However, studies using specific designs to control for
genetic confounding came to inconsistent results (e.g. [52,
58, 59]).
Eur Child Adolesc Psychiatry (2014) 23:913–929 923
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D’Onofrio et al. [58] recently assessed the relationship
between maternal smoking during pregnancy and antisocial
behaviour in adolescents aged 14–17 years. In unrelated
individuals, the results show a significantly increased risk
for antisocial behaviour symptoms and for a criminal
conviction. However, the associations became smaller and
lost statistical significance when comparing siblings who
differed in their exposure to prenatal maternal smoking.
This supports the influence of familial factors on the
association between prenatal exposure to smoking and later
development of antisocial behaviour. A similar result was
observed in an earlier study from D’Onofrio et al. [52] who
also did not observe any elevated risk for conduct problems
or oppositional defiant problems in children exposed to
prenatal maternal smoking compared to unexposed
siblings.
However, a very new study by Gaysina et al. [59] shows
a different picture. Using data from three studies, it sup-
ports a direct causal effect of prenatal maternal smoking on
later conduct problems in the offspring. Three different
genetic constellations for mother–child pairs were present:
either genetically related (1) or genetically unrelated with
an adoption of the child at birth (2) or at conception (3).
Thus, the authors were able to assess the association in
mother–child pairs who differed not only with respect to
tobacco smoke exposure during pregnancy but also with
respect to their genetic relationship. Children who were
exposed to maternal smoking in utero were observed to
have a higher risk of conduct problems, regardless of
whether the mother was genetically related or unrelated to
the child. This supports an adverse effect of the exposure
and not of genetic factors. This association was also
observed after adjustment for several potential confounders
among which were maternal education, parenting practices
and socioeconomic characteristics of the family. Further-
more, results of a meta-analysis across pairs in the three
studies supported this finding [59].
A possible explanation for differences between the
findings from the study of Gaysina et al. [59] and those
from D’Onofrio et al. [52, 58] is proposed by Gaysina
et al.: the inability of the latter two studies to account for
the influence of passive gene–environment correlations.
Contrary to a gene–environment interaction which refers to
a different susceptibility to an environmental factor due to
a certain genotype, gene–environment correlations are
described by a probability of exposure to an environmental
factor that differs with the genotype [60]. A passive gene–
environment correlation refers to the situation that children
with a certain genotype (that is inherited from the parents)
are more likely to experience a certain environmental
exposure occurring during childhood [60]. Gaysina et al.
[59] mentioned that they were able to control for post-natal
passive genotype–environment correlations by testing the
association in a subgroup of children adopted at birth who
share the post-natal environment, but no prenatal envi-
ronmental nor genetic factors with the mother. The asso-
ciation between prenatal smoke exposure and children’s
conduct problems was also present in this group.
In conclusion, existing literature suggests a causal effect
of prenatal exposure to nicotine and conduct or external-
ising problems in the offspring.
Depression, anxiety or internalising disorders
Results are generally mixed on the association between
maternal smoking during pregnancy and internalising
symptoms, such as depression or anxiety, in children.
Findings are therefore less consistent than the findings for
externalising symptoms such as conduct problems or
ADHD [61]. While some studies are supportive of a rela-
tionship (e.g. [61–64]), others are not (e.g. [19, 65]).
One longitudinal study by Ashford et al. [61] investigated
the association between maternal smoking during pregnancy
and symptoms of internalising behaviour in nearly 400 chil-
dren, assessed at ages 5, 10–11 and 18 years. The authors
observed significant relationships with both externalising and
internalising behaviours that were also robust to adjustment
for potential confounders and also for co-occurring internal-
ising and externalising behaviours, respectively. The authors
state that their study has the advantage of controlling for
comorbid externalising problems, as the association between
maternal smoking during pregnancy and externalising prob-
lems is well established and internalising and externalising
problems are often comorbid.
A similar result was observed from a small study of 84
children conducted by Indredavik et al. [62]. Maternally
reported internalising scores at the age of 14 years were
significantly higher for children whose mother smoked
during pregnancy, and this association remained also after
adjustment for confounders including socioeconomic status
and maternal mental health.
Menezes et al. [63] recently reported results from
18-year-olds from the Pelotas cohort, showing a higher risk
for lower levels of happiness and increased rates of
depression among those prenatally exposed to maternal
smoking (\20 cigarettes/day: OR = 1.38, 95 % CI:
1.03–1.84; C20 cigarettes/day: OR = 2.11, 95 % CI:
1.31–3.40). Smoking by the mother’s partner during
pregnancy was associated with decreased adolescent hap-
piness after adjustment for confounders, but did not show
an association with offspring depression.
Ekblad et al. [64] studied the relationship between
maternal smoking during pregnancy and psychiatric mor-
bidity in young Finnish adults in a large (N [ 175,000)
population-based sample using registry-based data. The
authors observed an increased risk for any psychiatric
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diagnosis. Dose–response relationships were observed for
the risks of mood disorders, behavioural and emotional
disorders occurring in childhood and adolescence, as well
as disorders of conduct and emotion. However, while the
study was able to adjust for a potential influence of
maternal psychiatric morbidity on the relationship, infor-
mation on other important factors such as socioeconomic
factors, maternal alcohol consumption during pregnancy
and post-natal exposure to tobacco smoke was not avail-
able. Therefore, the reported association should be inter-
preted with caution.
Other studies, however, do not observe a relationship
between prenatal maternal smoking and internalising
problems. Ho¨o¨k et al. [65] observed no such association in
preschool children at 3 or at 5.5 years of age. A similar null
finding was observed by Brion et al. [19] who studied the
association in the British ALSPAC and the Brazilian Pe-
lotas study. Another finding of this study was that paternal
smoking during pregnancy was also unrelated to offspring
internalising problems [19].
A small number of studies in rats on internalising
behaviours after prenatal nicotine exposure reported con-
sistent results of an increased anxiety-like behaviour in
adolescent and also in adult rats [31].
In summary, the establishment of a final conclusion
concerning the relationship between prenatal nicotine
exposure and internalising problems in the offspring is
complicated by insufficient data and mixed results in epi-
demiological studies.
Developmental aspects: neonate, infant, child,
adolescent and adult
Taking together the results from above, maternal active or
passive smoking during pregnancy correlates with behav-
ioural problems in the offspring across the lifespan. How-
ever, even if no study had had the possibility to investigate
the longitudinal association from birth to adulthood, the
results from offspring at different ages seem to support a
long-lasting relationship.
Central nervous system (CNS) findings
Bublitz et al. [66] reviewed the results from the small
number of studies investigating the association between
maternal smoking during pregnancy and brain structure
and function in human offspring, and concluded that this
exposure has adverse effects. Structural changes in the
foetal or early post-natal period included smaller volumes
of cerebellum and lateral ventricular system and a smaller
frontal lobe [66]. Structural changes in children and
adolescents exposed to gestational tobacco smoke included
reduced grey matter volume in the cerebral cortex, smaller
volume of the corpus callosum and thinning in the frontal,
temporal and parietal regions [66]. Reduced volume of the
corpus callosum and cerebellum was also observed in
children with ADHD [67], thereby providing a potential
link between in utero exposure to tobacco smoke and
ADHD. Furthermore, comparative functional magnetic
resonance imaging studies showed inferior frontal cortex
underactivation in children with ADHD which is suggested
to be disorder-specific for ADHD [68]. Imaging studies of
conduct disorders showed dysfunctions of the paralimbic
system which were disorder-specific when compared to
children with ADHD [68].
Bublitz et al. [66] reported an increased rate of auditory
brainstem responses in infants whose mother smoked
during pregnancy, providing a link to cognitive deficits or
language and learning impairments.
Mechanisms underlying teratogenesis and/or effects
on the CNS
Nicotine is one of thousands of components of tobacco
smoke, but it is this chemical that most probably has
adverse effects on brain development [53]. The effects of
nicotine are thought to occur via its action on nicotinic
acetylcholine receptors (nAChRs). These receptors are
ligand-gated ion channels expressed in the CNS, in the
peripheral nervous system and also in non-neuronal cells
that operate through binding and release of a signalling
molecule which, in the case of nAChRs, is the endogenous
neurotransmitter acetylcholine (ACh) [69]. Nicotine is an
exogenous agonist of ACh, able to bind to and to desen-
sitise these nAChRs and thereby mimics the action of ACh
[53]. It is suggested that ACh through its action on nAChRs
plays an important role in brain maturation in foetuses and
infants up to adolescence [53]. These processes modulated
by ACh can thus be perturbed by nicotine. Expression of
nAChRs subunit mRNA is reported in the first trimester of
human foetuses [70], and its expression varies among brain
regions and time but seems to be comparable between
humans and rodents [53]. Therefore, nicotine exposure at
different periods of maturation could elicit different
developmental deficits [53]. There is further evidence for
the involvement of nAChRs in the control of CNS matu-
ration by modulating, for example, gene expression, cell
proliferation, differentiation and apoptosis [70]. Results
from animal studies also suggest that gestational exposure
to nicotine is related to cell death in neurons [70]. NAChRs
are also thought to be involved in the development of the
catecholamine neurotransmitter systems via regulation of
neurotransmitter release [70]. This provides a link to
Eur Child Adolesc Psychiatry (2014) 23:913–929 925
123
behavioural problems in children as these may be a result
from catecholaminergic dysfunction that could potentially
be caused by nicotine that perturbed a proper development
[53]. Arnsten and Rubia [68] reviewed the role of neuro-
biological circuits involved in the regulation of behaviour
and cognitive function and their relationship to neurode-
velopmental disorders in children. The prefrontal cortex
(PFC) plays here an important role which is dependent on
optimal levels of neurotransmitters such as the catechola-
mines dopamine and norepinephrine, serotonin and ACh
[68]. A reduced function of the prefrontal cortex is related
to symptoms of ADHD [71]. Treatment with methylphe-
nidate, a stimulant medication for ADHD in children,
increases the levels of dopamine and norepinephrine in the
PFC by blocking transporters responsible for the clearance
of these neurotransmitters and thereby improves the PFC’s
function to control attention and working memory [68].
Moylan et al. [72] reviewed possible biological
mechanisms that might be involved in the relationship
between in utero tobacco smoke exposure and anxiety
symptoms or disorder. Among these is a role of neuro-
transmitter systems, such as serotonin, noradrenaline and
dopamine. As mentioned above, these systems might be
affected by prenatal exposure to nicotine. Furthermore,
dysfunction of norepinephrine and serotonin neurotrans-
mitter systems has been related to depression and anxiety
[73, 74].
Another approach for understanding the influence of
maternal smoking on child behaviour problems is the
investigation of epigenetic mechanisms [75, 76]. Prenatal
smoking has been linked to alterations in placental DNA
methylation and gene expression [77], decreased global
DNA methylation in cord blood relative to cord serum
cotinine levels [78] and to increased DNA methylation in
the brain-derived neurotrophic factor-6 exon in adoles-
cence [79]. However, the implications of these findings for
behavioural outcomes in the offspring are not yet clear
[75].
Conclusion
Many studies report relationships between maternal
smoking during pregnancy and behavioural problems or
impaired cognitive function in the offspring, and plausible
biological mechanisms exist via which nicotine could
affect the development of the foetus in utero. The link of
prenatal smoke exposure with externalising problems or
ADHD seems to be more consistent than that with inter-
nalising problems. However, establishing a statement on
the causality of the relationship between prenatal nicotine
exposure and behavioural problems in children remains
challenging.
But, do we really need more research on the direct
causality between prenatal exposure to nicotine and
behavioural problems to recommend abstinence from
smoking during pregnancy and the avoidance of a smoke
exposure of the expectant mother? We think that further
studies are likely unnecessary! This final statement is not
only justified by an increasing number of studies which
link prenatal exposure to nicotine to externalising problems
applying different methodologies to account for con-
founding but also by other adverse health effects known to
be caused by prenatal nicotine exposure. Therefore, parents
should consider smoking cessation to prevent adverse
health effects for their child.
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